May 13
|
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
|
May 10
|
Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
May 9
|
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript
|
May 9
|
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
|
May 9
|
Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
|
May 9
|
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
|
May 8
|
Maravai LifeSciences Reports First Quarter 2024 Financial Results
|
Apr 30
|
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
|
Apr 18
|
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
|
Apr 10
|
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
|
Mar 19
|
Should You Sell Maravai LifeSciences (MRVI)?
|
Mar 12
|
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
|
Feb 23
|
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2023 Earnings Call Transcript
|
Feb 23
|
Q4 2023 Maravai LifeSciences Holdings Inc Earnings Call
|
Feb 23
|
Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript
|
Feb 22
|
Maravai LifeSciences Holdings Inc (MRVI) Faces Net Loss in 2023 Despite Revenue Outperformance
|
Feb 22
|
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 21
|
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
|
Jan 29
|
Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
|
Dec 18
|
Bank of America Pounds the Table on These 3 Buy-Rated Stocks
|